Savara's valuation will be heavily impacted by the results of its upcoming IMPALA-2 trial for its drug Molgramostim. Learn ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Targeting a special protein called PD-1 allows cancer treatments such as Keytruda and Opdivo to boost the immune system’s ...

Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). Reshaping the tumor microenvironment of ...

Ryan attended The Loomis Chaffee School and graduated from Babson College in 1998. The Family suggests contributions be made to The Alliance Against Alveolar Soft Part Sarcoma (TAAASPS).

Periodontal disease, represented by periodontitis, is the leading cause of tooth loss and affects close to one in five adults ...

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...

The Medford Fire District used one of their trucks to give Evelyn -- a Sparrow who is battling cancer -- a proper send-off.

In a new study, researchers from IISc propose the induction of a class of drugs called pranlukast (PRK) in anti-tubercular therapeutics for efficacious healing of lung tissues in TB-infected ...